XM does not provide services to residents of the United States of America.
P
P

Pfizer

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

U.S. STOCKS Pure Cycle, Tesla, Five9

BUZZ-U.S. STOCKS ON THE MOVE-Pure Cycle, Tesla, Five9 Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 fell from record highs on Thursday, weighed by megacap stocks, as investors favored small-caps after a softer-than-expected inflation reading bolstered hopes that the U.S.
A
A
B
C
C
C
F
I
P
P
P
T
V
D
W
U
U
E

U.S. STOCKS Delta Air Lines, Crypto stocks, Solar stocks

BUZZ-U.S. STOCKS ON THE MOVE-Delta Air Lines, Crypto stocks, Solar stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes struggled for direction on Thursday as investors favored rate-sensitive small-cap stocks over expensive megacaps after a softer-than-expected inflation reading bolstered hopes for monetary policy easing in September.
A
B
C
C
F
N
P
P
P
V
L
A
W
U
U
I
M
R

U.S. STOCKS Alcoa, 40, Broadcom

BUZZ-U.S. STOCKS ON THE MOVE-Alcoa, WD-40, Broadcom Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street futures turned positive on Thursday after data showed inflation eased in June, boosting expectations of
A
B
C
C
P
P
P
V
L
W
U
R

Wall Street set for stronger open after inflation print; airlines slump on Delta forecast

US STOCKS-Wall Street set for stronger open after inflation print; airlines slump on Delta forecast CPI data shows inflation eased in June PepsiCo dips on quarterly revenue miss Pfizer moves ahead with once-daily weight-loss pill, shares up Futures up: Dow 0.17%, S&P 500 0.22%, Nasdaq 0.28% Updated at 8:42 a.m. ET/1242 GMT By Lisa Pauline Mattackal and Ankika Biswas July 11 (Reuters) - Wall Street futures turned positive on Thursday after data showed inflation eased in June, boosting expectation
A
J
N
P
P
A
U
U
U
U
A

Pfizer's move to press ahead with weight-loss pill drags some drug developers

BUZZ-Pfizer's move to press ahead with weight-loss pill drags some drug developers Updates ** Shares of weight-loss drug developer Viking Therapeutics VKTX.O fall ~4.3% to $55.50 premarket ** Pfizer PFE.N plans to advance a reworked, once-a-day version of its experimental obesity pill, danuglipron, to clinical trials in the second half of this year
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.